| Year |
Citation |
Score |
| 2022 |
Lennard Richard ML, Wirth JR, Khatiwada A, Chung D, Gilkeson GS, Cunningham MA. Conditional knockout of ERα in CD11c+ cells impacts female survival and inflammatory cytokine profile in murine lupus. Immunology. PMID 35778961 DOI: 10.1111/imm.13541 |
0.33 |
|
| 2021 |
Wang X, Oates JC, Helke KL, Gilkeson GS, Zhang XK. Camptothecin and topotecan, inhibitors of transcription factor Fli-1 and topoisomerase, markedly ameliorate lupus nephritis in NZBWF1 mice and reduce the production of inflammatory mediators in human renal cells. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33559345 DOI: 10.1002/art.41685 |
0.316 |
|
| 2020 |
Nowling TK, Rodgers J, Thiyagarajan T, Wolf B, Bruner E, Sundararaj K, Molano I, Gilkeson G. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. Plos One. 15: e0230499. PMID 32187230 DOI: 10.1371/Journal.Pone.0230499 |
0.417 |
|
| 2020 |
Johnson BM, Gaudreau MC, Gudi R, Brown R, Gilkeson G, Vasu C. Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice. Journal of Autoimmunity. 102420. PMID 32019684 DOI: 10.1016/J.Jaut.2020.102420 |
0.351 |
|
| 2019 |
Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Annals of the Rheumatic Diseases. PMID 31217170 DOI: 10.1136/Annrheumdis-2019-215361 |
0.333 |
|
| 2019 |
Zhou Z, Bian C, Luo Z, Guille C, Ogunrinde E, Wu J, Zhao M, Fitting S, Kamen DL, Oates JC, Gilkeson G, Jiang W. Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and Caco-2 cells. Scientific Reports. 9: 8367. PMID 31182728 DOI: 10.1038/S41598-019-44448-0 |
0.336 |
|
| 2019 |
Ogunrinde E, Zhou Z, Luo Z, Alekseyenko A, Li QZ, Macedo D, Kamen DL, Oates JC, Gilkeson GS, Jiang W. A link between plasma microbial translocation, microbiome, and autoantibody development in first-degree relatives of systemic lupus erythematosus patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31106972 DOI: 10.1002/Art.40935 |
0.324 |
|
| 2019 |
Wirth J, Coutermarsh-Ott S, Molano I, Gilkeson GS, Cunningham MA. 70 R848 (Resiquimod), a TLR 7/8 agonist, accelerates disease and causes a fatal myeloproliferative disorder in NZM 2410 lupus-prone mice Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.70 |
0.44 |
|
| 2019 |
Richard ML, Cunningham MA, Tsao B, Gilkeson GS. 180 Examining the transcriptional impact of liganded estrogen receptor alpha in the inflammatory milieu of systemic lupus erythematosus Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.180 |
0.428 |
|
| 2018 |
Cunningham MA, Richard ML, Wirth JR, Scott JL, Eudaly J, Ruiz P, Gilkeson GS. Novel mechanism for estrogen receptor alpha modulation of murine lupus. Journal of Autoimmunity. PMID 30416032 DOI: 10.1016/J.Jaut.2018.10.011 |
0.434 |
|
| 2018 |
Pan F, Tang W, Zhou Z, Gilkeson G, Lang R, Jiang W. Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease. Lupus. 961203318797417. PMID 30223707 DOI: 10.1177/0961203318797417 |
0.359 |
|
| 2018 |
Martínez-Bueno M, Oparina N, Dozmorov MG, Marion MC, Comeau ME, Gilkeson G, Kamen D, Weisman M, Salmon J, McCune JW, Harley JB, Kimberly R, James JA, Merrill J, Montgomery C, et al. Trans-Ethnic Mapping of Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks. International Journal of Molecular Sciences. 19. PMID 30096841 DOI: 10.3390/Ijms19082331 |
0.355 |
|
| 2018 |
Patel Z, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, ... ... Gilkeson GS, et al. A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Human Molecular Genetics. PMID 29912393 DOI: 10.1093/Hmg/Ddy140 |
0.354 |
|
| 2018 |
Wallace CH, Wu BX, Salem M, Ansa-Addo EA, Metelli A, Sun S, Gilkeson G, Shlomchik MJ, Liu B, Li Z. B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. Jci Insight. 3. PMID 29618665 DOI: 10.1172/Jci.Insight.99863 |
0.37 |
|
| 2018 |
Richard ML, Gilkeson G. Mouse models of lupus: what they tell us and what they don't. Lupus Science & Medicine. 5: e000199. PMID 29387435 DOI: 10.1136/Lupus-2016-000199 |
0.365 |
|
| 2017 |
Zhou Z, Zhang L, Ding M, Luo Z, Yuan S, Bansal MB, Gilkeson G, Lang R, Jiang W. Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues. Clinical Immunology (Orlando, Fla.). PMID 28867253 DOI: 10.1016/J.Clim.2017.08.019 |
0.307 |
|
| 2017 |
Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, ... ... Gilkeson GS, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 8: 16021. PMID 28714469 DOI: 10.1038/Ncomms16021 |
0.337 |
|
| 2017 |
Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang SY, Lee HS, Li QZ, Wakeland EK, Qiu R, Liu M, Guo J, Li Z, Tan W, Rasmussen A, ... ... Gilkeson GS, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nature Genetics. PMID 28135245 DOI: 10.1038/Ng.3782 |
0.365 |
|
| 2016 |
Scott JL, Wirth JR, EuDaly JG, Gilkeson GS, Cunningham MA. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. Clinical Immunology (Orlando, Fla.). PMID 28041989 DOI: 10.1016/J.Clim.2016.12.009 |
0.42 |
|
| 2016 |
Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA. Soluble Mediators and Clinical Features Discern Risk of Transitioning to Classified Disease in Relatives of Systemic Lupus Erythematosus Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27863174 DOI: 10.1002/Art.40004 |
0.34 |
|
| 2016 |
Zhou Z, Ding M, Huang L, Gilkeson G, Lang R, Jiang W. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases. Clinical Immunology (Orlando, Fla.). PMID 27620642 DOI: 10.1016/J.Clim.2016.09.005 |
0.344 |
|
| 2016 |
Richard ML, Brandon D, Lou N, Sato S, Caldwell T, Nowling TK, Gilkeson G, Zhang XK. Acetylation impacts Fli-1 driven regulation of granulocyte colony stimulating factor. European Journal of Immunology. PMID 27431361 DOI: 10.1002/Eji.201646315 |
0.353 |
|
| 2016 |
Cunningham MA, Wirth JR, Scott JL, Eudaly J, Collins EL, Gilkeson GS. Early Ovariectomy Results in Reduced Numbers of CD11c+/CD11b+ Spleen Cells and Impacts Disease Expression in Murine Lupus. Frontiers in Immunology. 7: 31. PMID 26913030 DOI: 10.3389/Fimmu.2016.00031 |
0.421 |
|
| 2016 |
Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, ... ... Gilkeson GS, et al. Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Annals of the Rheumatic Diseases. PMID 26783109 DOI: 10.1136/Annrheumdis-2015-208441 |
0.329 |
|
| 2016 |
Cunningham MA, Wirth J, Scott J, Eudaly J, Gilkeson GS. II-01 An oestrogen receptor alpha functional mutant is protective in murine lupus Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.31 |
0.436 |
|
| 2016 |
Amrhein T, Passo M, Gilkeson G, Ruth N. Childhood-onset Systemic Lupus Erythematosus Complicated by Posterior Reversible Encephalopathy Syndrome in The Context of Kidney Dialysis and Plasma Exchange in Pediatric Lupus Journal of Pediatric Neurology. 14: 105-109. DOI: 10.1055/S-0036-1587600 |
0.308 |
|
| 2015 |
Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, ... ... Gilkeson GS, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26713507 DOI: 10.1002/Art.39560 |
0.306 |
|
| 2015 |
Scott JL, Cunningham MA, Naga OS, Wirth JR, Eudaly JG, Gilkeson GS. Estrogen Receptor α Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 26553076 DOI: 10.4049/Jimmunol.1500315 |
0.444 |
|
| 2015 |
Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, et al. Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). PMID 26385092 DOI: 10.1016/J.Clim.2015.09.007 |
0.347 |
|
| 2015 |
Buyon JP, Cohen P, Merrill JT, Gilkeson G, Kaplan M, James J, McCune WJ, Bernatsky S, Elkon K. A highlight from the LUPUS 2014 meeting: eight great ideas. Lupus Science & Medicine. 2: e000087. PMID 26167290 DOI: 10.1136/Lupus-2015-000087 |
0.313 |
|
| 2015 |
Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, ... ... Gilkeson GS, et al. Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. American Journal of Human Genetics. 96: 731-9. PMID 25865496 DOI: 10.1016/J.Ajhg.2015.03.002 |
0.358 |
|
| 2015 |
Gilkeson G, Manzi S. Dialogue: Vitamin D, statins and atherosclerotic progression in paediatric lupus Lupus Science & Medicine. 2. PMID 25685366 DOI: 10.1136/Lupus-2015-000081 |
0.311 |
|
| 2015 |
Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, ... ... Gilkeson G, et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 24: 582-96. PMID 25205108 DOI: 10.1093/Hmg/Ddu455 |
0.37 |
|
| 2014 |
Vaughn SE, Foley C, Lu X, Patel ZH, Zoller EE, Magnusen AF, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath S, Stevens AM, ... ... Gilkeson GS, et al. Lupus risk variants in the PXK locus alter B-cell receptor internalization. Frontiers in Genetics. 5: 450. PMID 25620976 DOI: 10.3389/Fgene.2014.00450 |
0.384 |
|
| 2014 |
Cunningham MA, Wirth JR, Freeman LR, Boger HA, Granholm AC, Gilkeson GS. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. Journal of Neuroinflammation. 11: 171. PMID 25510908 DOI: 10.1186/S12974-014-0171-X |
0.392 |
|
| 2014 |
Jiang W, Zhang L, Lang R, Li Z, Gilkeson G. Sex differences in monocyte activation in systemic lupus erythematosus (SLE). Plos One. 9: e114589. PMID 25485543 DOI: 10.1371/Journal.Pone.0114589 |
0.402 |
|
| 2014 |
Svenson J, Cunningham M, Dasgupta S, Gilkeson GS. Estrogen receptor alpha modulates mesangial cell responses to toll-like receptor ligands. The American Journal of the Medical Sciences. 348: 492-500. PMID 25343264 DOI: 10.1097/Maj.0000000000000339 |
0.793 |
|
| 2014 |
Collins E, Gu F, Qi M, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential efficacy of human mesenchymal stem cells based on source of origin. Journal of Immunology (Baltimore, Md. : 1950). 193: 4381-90. PMID 25274529 DOI: 10.4049/Jimmunol.1401636 |
0.326 |
|
| 2014 |
Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, ... ... Gilkeson GS, et al. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Annals of the Rheumatic Diseases. PMID 25180293 DOI: 10.1136/Annrheumdis-2014-205584 |
0.342 |
|
| 2014 |
Cunningham M, Marks N, Barnado A, Wirth JR, Gilkeson G, Markiewicz M. Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. Seminars in Thrombosis and Hemostasis. 40: 675-81. PMID 25173498 DOI: 10.1055/S-0034-1387924 |
0.35 |
|
| 2014 |
Sato S, Lennard Richard M, Brandon D, Jones Buie JN, Oates JC, Gilkeson GS, Zhang XK. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3436-44. PMID 25155007 DOI: 10.1002/Art.38818 |
0.323 |
|
| 2014 |
Guthridge JM, Lu R, Sun H, Sun C, Wiley GB, Dominguez N, Macwana SR, Lessard CJ, Kim-Howard X, Cobb BL, Kaufman KM, Kelly JA, Langefeld CD, Adler AJ, Harley IT, ... ... Gilkeson GS, et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. American Journal of Human Genetics. 94: 586-98. PMID 24702955 DOI: 10.1016/J.Ajhg.2014.03.008 |
0.355 |
|
| 2013 |
Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, Alarcόn-Riquelme ME, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, ... ... Gilkeson GS, et al. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. Plos Genetics. 9: e1003870. PMID 24130510 DOI: 10.1371/Journal.Pgen.1003870 |
0.302 |
|
| 2013 |
Oates JC, Mashmoushi AK, Shaftman SR, Gilkeson GS. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 22: 1361-1370. PMID 24106214 DOI: 10.1177/0961203313507988 |
0.312 |
|
| 2013 |
Caster DJ, Korte EA, Nanda SK, McLeish KR, Oliver RK, G'sell RT, Sheehan RM, Freeman DW, Coventry SC, Kelly JA, Guthridge JM, James JA, Sivils KL, Alarcon-Riquelme ME, Scofield RH, ... ... Gilkeson GS, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. Journal of the American Society of Nephrology : Jasn. 24: 1743-54. PMID 23970121 DOI: 10.1681/Asn.2013020148 |
0.419 |
|
| 2013 |
Namjou B, Kim-Howard X, Sun C, Adler A, Chung SA, Kaufman KM, Kelly JA, Glenn SB, Guthridge JM, Scofield RH, Kimberly RP, Brown EE, Alarcón GS, Edberg JC, Kim JH, ... ... Gilkeson GS, et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. Plos One. 8: e69404. PMID 23950893 DOI: 10.1371/Journal.Pone.0069404 |
0.311 |
|
| 2013 |
Manku H, Langefeld CD, Guerra SG, Malik TH, Alarcon-Riquelme M, Anaya JM, Bae SC, Boackle SA, Brown EE, Criswell LA, Freedman BI, Gaffney PM, Gregersen PA, Guthridge JM, Han SH, ... ... Gilkeson GS, et al. Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. Plos Genetics. 9: e1003554. PMID 23874208 DOI: 10.1371/Journal.Pgen.1003554 |
0.31 |
|
| 2013 |
Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. Plos One. 8: e64650. PMID 23741359 DOI: 10.1371/Journal.Pone.0064650 |
0.428 |
|
| 2013 |
Ramos PS, Oates JC, Kamen DL, Williams AH, Gaffney PM, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Jacob CO, Tsao BP, Alarcón GS, Brown EE, Edberg JC, Petri MA, ... ... Gilkeson GS, et al. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. The Journal of Rheumatology. 40: 842-9. PMID 23637325 DOI: 10.3899/Jrheum.120989 |
0.316 |
|
| 2013 |
Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson GS, Jacob CO, Scofield RH, Langefeld CD, Kelly JA, Ramsey-Goldman R, Petri MA, Reveille JD, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. Plos Genetics. 9: e1003336. PMID 23468661 DOI: 10.1371/Journal.Pgen.1003336 |
0.345 |
|
| 2013 |
Molineros JE, Maiti AK, Sun C, Looger LL, Han S, Kim-Howard X, Glenn S, Adler A, Kelly JA, Niewold TB, Gilkeson GS, Brown EE, Alarcón GS, Edberg JC, Petri M, et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. Plos Genetics. 9: e1003222. PMID 23441136 DOI: 10.1371/Journal.Pgen.1003222 |
0.366 |
|
| 2013 |
Suzuki E, Williams S, Sato S, Gilkeson G, Watson DK, Zhang XK. The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice Immunology. 139: 318-327. PMID 23320737 DOI: 10.1111/Imm.12070 |
0.416 |
|
| 2013 |
Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplantation. 22: 2279-90. PMID 23127285 DOI: 10.3727/096368912X658692 |
0.41 |
|
| 2013 |
Baker DA, Eudaly J, Smith CD, Obeid LM, Gilkeson GS. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis. Rheumatology International. 33: 2677-81. PMID 23011090 DOI: 10.1007/S00296-012-2493-2 |
0.664 |
|
| 2013 |
Kaufman KM, Zhao J, Kelly JA, Hughes T, Adler A, Sanchez E, Ojwang JO, Langefeld CD, Ziegler JT, Williams AH, Comeau ME, Marion MC, Glenn SB, Cantor RM, Grossman JM, ... ... Gilkeson GS, et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Annals of the Rheumatic Diseases. 72: 437-44. PMID 22904263 DOI: 10.1136/Annrheumdis-2012-201851 |
0.323 |
|
| 2013 |
Markiewicz M, Znoyko S, Stawski L, Ghatnekar A, Gilkeson G, Trojanowska M. A role for estrogen receptor-α and estrogen receptor-β in collagen biosynthesis in mouse skin. The Journal of Investigative Dermatology. 133: 120-7. PMID 22895361 DOI: 10.1038/Jid.2012.264 |
0.34 |
|
| 2012 |
Suzuki E, Karam E, Williams S, Watson DK, Gilkeson G, Zhang XK. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney Clinical Immunology. 145: 201-208. PMID 23108091 DOI: 10.1016/J.Clim.2012.09.006 |
0.458 |
|
| 2012 |
Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clinical Immunology (Orlando, Fla.). 145: 142-52. PMID 23041504 DOI: 10.1016/J.Clim.2012.08.012 |
0.338 |
|
| 2012 |
Lu R, Robertson JM, Bruner BF, Guthridge JM, Neas BR, Nath SK, Kelly JA, Moser Sivils KL, Chakravarty EF, Kamen DL, Gilkeson GS, Wallace DJ, Weisman MH, Scofield RH, Harley JB, et al. Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort. Autoimmune Diseases. 2012: 819634. PMID 22988489 DOI: 10.1155/2012/819634 |
0.341 |
|
| 2012 |
Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, Lu L, Zeng X, Sun L. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clinical & Developmental Immunology. 2012: 826182. PMID 22966240 DOI: 10.1155/2012/826182 |
0.34 |
|
| 2012 |
Sánchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, GarcÃa-De La Torre I, Maradiaga-Ceceña MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, ... ... Gilkeson GS, et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis and Rheumatism. 64: 3687-94. PMID 22886787 DOI: 10.1002/Art.34650 |
0.301 |
|
| 2012 |
Adrianto I, Wang S, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, Glenn SB, Williams AH, Ziegler JT, Comeau ME, Marion MC, Wakeland BE, Liang C, Kaufman KM, Guthridge JM, ... ... Gilkeson GS, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3695-705. PMID 22833143 DOI: 10.1002/Art.34642 |
0.379 |
|
| 2012 |
Cunningham MA, Naga OS, Eudaly JG, Scott JL, Gilkeson GS. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clinical Immunology (Orlando, Fla.). 144: 1-12. PMID 22659029 DOI: 10.1016/J.Clim.2012.04.001 |
0.471 |
|
| 2012 |
Kim K, Brown EE, Choi CB, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Lee HS, Boackle SA, Criswell LA, Alarcón GS, Edberg JC, Stevens AM, ... ... Gilkeson GS, et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Annals of the Rheumatic Diseases. 71: 1809-14. PMID 22523428 DOI: 10.1136/Annrheumdis-2011-201110 |
0.319 |
|
| 2012 |
Wang S, Adrianto I, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, Glenn SB, Williams AH, Ziegler JT, Comeau ME, Marion MC, Wakeland BE, Liang C, Kaufman KM, Guthridge JM, ... ... Gilkeson GS, et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes and Immunity. 13: 380-7. PMID 22476155 DOI: 10.1038/Gene.2012.6 |
0.369 |
|
| 2012 |
Lessard CJ, Adrianto I, Ice JA, Wiley GB, Kelly JA, Glenn SB, Adler AJ, Li H, Rasmussen A, Williams AH, Ziegler J, Comeau ME, Marion M, Wakeland BE, Liang C, ... ... Gilkeson GS, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. American Journal of Human Genetics. 90: 648-60. PMID 22464253 DOI: 10.1016/J.Ajhg.2012.02.023 |
0.334 |
|
| 2012 |
Namjou B, Choi CB, Harley IT, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Kim K, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown EE, ... ... Gilkeson GS, et al. Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis and Rheumatism. 64: 1960-9. PMID 22231568 DOI: 10.1002/Art.34361 |
0.36 |
|
| 2012 |
Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, ... ... Gilkeson GS, et al. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes and Immunity. 13: 232-8. PMID 22189356 DOI: 10.1038/Gene.2011.82 |
0.339 |
|
| 2012 |
Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcón-Riquelme ME, Tikly M, Ramsey-Goldman R, ... ... Gilkeson GS, et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71: 463-8. PMID 22088620 DOI: 10.1136/Annrheumdis-2011-200463 |
0.392 |
|
| 2012 |
Castillejo-López C, Delgado-Vega AM, Wojcik J, Kozyrev SV, Thavathiru E, Wu YY, Sánchez E, Pöllmann D, López-Egido JR, Fineschi S, Domínguez N, Lu R, James JA, Merrill JT, Kelly JA, ... ... Gilkeson G, et al. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Annals of the Rheumatic Diseases. 71: 136-42. PMID 21978998 DOI: 10.1136/Annrheumdis-2011-200085 |
0.355 |
|
| 2012 |
Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, ... ... Gilkeson GS, et al. Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 485-92. PMID 21952918 DOI: 10.1002/Art.33354 |
0.315 |
|
| 2012 |
Deng Y, Zhao J, Sakurai D, Kaufman K, Edberg J, Kimberly R, Kamen D, Gilkeson G, Jacob C, Scofield R, Langefeld C, Kelly J, Alarcón-Riquelme M, Harley J, Vyse T, et al. MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant Arthritis Research & Therapy. 14: 1-28. DOI: 10.1186/Ar3939 |
0.34 |
|
| 2011 |
Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Research & Therapy. 13: 250. PMID 22192660 DOI: 10.1186/Ar3528 |
0.336 |
|
| 2011 |
Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL. Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population. Lupus. 21: 563-9. PMID 22031537 DOI: 10.1177/0961203311426154 |
0.311 |
|
| 2011 |
Sekine H, Ruiz P, Gilkeson GS, Tomlinson S. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. Molecular Immunology. 49: 317-23. PMID 22000720 DOI: 10.1016/J.Molimm.2011.09.015 |
0.407 |
|
| 2011 |
Gilkeson GS, James JA, Kamen DL, Knackstedt TJ, Maggi DR, Meyer AK, Ruth NM. The United States to Africa lupus prevalence gradient revisited Lupus. 20: 1095-1103. PMID 21917913 DOI: 10.1177/0961203311404915 |
0.326 |
|
| 2011 |
Baker DA, Obeid LM, Gilkeson GS. Impact of sphingosine kinase on inflammatory pathways in fibroblast-like synoviocytes. Inflammation & Allergy Drug Targets. 10: 464-71. PMID 21864273 DOI: 10.2174/187152811798104863 |
0.662 |
|
| 2011 |
Li P, Cook JA, Gilkeson GS, Luttrell LM, Wang L, Borg KT, Halushka PV, Fan H. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Molecular Immunology. 49: 64-74. PMID 21855149 DOI: 10.1016/J.Molimm.2011.07.021 |
0.329 |
|
| 2011 |
Sánchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vilá LM, Merrill JT, ... ... Gilkeson GS, et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis and Rheumatism. 63: 3493-501. PMID 21792837 DOI: 10.1002/Art.30563 |
0.303 |
|
| 2011 |
Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, Langefeld CD, Alarcón GS, Edberg JC, Ramsey-Goldman R, Petri M, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1752-7. PMID 21719445 DOI: 10.1136/Ard.2011.154104 |
0.325 |
|
| 2011 |
Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Adler A, Glenn SB, Alarcón-Riquelme ME, ... ... Gilkeson GS, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. Plos Genetics. 7: e1002079. PMID 21637784 DOI: 10.1371/Journal.Pgen.1002079 |
0.331 |
|
| 2011 |
Tan W, Sunahori K, Zhao J, Deng Y, Kaufman KM, Kelly JA, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Bae SC, Lee JH, Lee JS, Chang DM, ... ... Gilkeson GS, et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis and Rheumatism. 63: 2755-63. PMID 21590681 DOI: 10.1002/Art.30452 |
0.367 |
|
| 2011 |
Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis and Rheumatism. 63: 1076-85. PMID 21452327 DOI: 10.1002/Art.30222 |
0.399 |
|
| 2011 |
Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, Guthridge JM, Alarcón-Riquelme ME, Anaya JM, Bae SC, ... ... Gilkeson GS, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nature Genetics. 43: 253-8. PMID 21336280 DOI: 10.1038/Ng.766 |
0.364 |
|
| 2011 |
Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcón-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown E, Edberg J, Stevens AM, Jacob CO, ... ... Gilkeson GS, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes and Immunity. 12: 270-9. PMID 21270825 DOI: 10.1038/Gene.2010.73 |
0.306 |
|
| 2011 |
Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, Adler A, Williams AH, Gallant CJ, Anaya JM, Bae SC, Boackle SA, Brown EE, Chang DM, Criswell LA, ... ... Gilkeson GS, et al. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. American Journal of Human Genetics. 88: 83-91. PMID 21194677 DOI: 10.1016/J.Ajhg.2010.11.014 |
0.302 |
|
| 2011 |
Oates JC, Halushka PV, Hutchison FN, Ruiz P, Gilkeson GS. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. The American Journal of the Medical Sciences. 341: 101-5. PMID 20924284 DOI: 10.1097/Maj.0B013E3181F56D2C |
0.341 |
|
| 2011 |
Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, Nath SK, Bruner G, Alarcón-Riquelme ME, Gilkeson GS, Kamen DL, Richardson BC, Harley JB, Sawalha AH. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Annals of the Rheumatic Diseases. 70: 151-6. PMID 20881011 DOI: 10.1136/Ard.2010.141697 |
0.34 |
|
| 2011 |
Cunningham M, Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clinical Reviews in Allergy & Immunology. 40: 66-73. PMID 20352526 DOI: 10.1007/S12016-010-8203-5 |
0.375 |
|
| 2010 |
Morris EE, Amria MY, Kistner-Griffin E, Svenson JL, Kamen DL, Gilkeson GS, Nowling TK. A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis. Arthritis Research & Therapy. 12: R212. PMID 21087477 DOI: 10.1186/Ar3189 |
0.78 |
|
| 2010 |
Parks CG, Biagini RE, Cooper GS, Gilkeson GS, Dooley MA. Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset allergies. Lupus. 19: 1614-22. PMID 20937624 DOI: 10.1177/0961203310379870 |
0.332 |
|
| 2010 |
Moussa O, LaRue AC, Abangan RS, Williams CR, Zhang XK, Masuya M, Gong YZ, Spyropoulos DD, Ogawa M, Gilkeson G, Watson DK. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Molecular and Cellular Biology. 30: 5194-206. PMID 20823267 DOI: 10.1128/Mcb.01112-09 |
0.387 |
|
| 2010 |
Mathenia J, Reyes-Cortes E, Williams S, Molano I, Ruiz P, Watson DK, Gilkeson GS, Zhang XK. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clinical and Experimental Immunology. 162: 362-71. PMID 20731671 DOI: 10.1111/J.1365-2249.2010.04245.X |
0.442 |
|
| 2010 |
Rohrer B, Long Q, Coughlin B, Renner B, Huang Y, Kunchithapautham K, Ferreira VP, Pangburn MK, Gilkeson GS, Thurman JM, Tomlinson S, Holers VM. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Advances in Experimental Medicine and Biology. 703: 137-49. PMID 20711712 DOI: 10.1007/978-1-4419-5635-4_10 |
0.323 |
|
| 2010 |
Harley IT, Niewold TB, Stormont RM, Kaufman KM, Glenn SB, Franek BS, Kelly JA, Kilpatrick JR, Hutchings D, Divers J, Bruner GR, Edberg JC, McGwin G, Petri MA, Ramsey-Goldman R, ... ... Gilkeson GS, et al. The role of genetic variation near interferon-kappa in systemic lupus erythematosus. Journal of Biomedicine & Biotechnology. 2010. PMID 20706608 DOI: 10.1155/2010/706825 |
0.358 |
|
| 2010 |
Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, Zeng X, Shi S, Sun L. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 19: 1502-14. PMID 20647254 DOI: 10.1177/0961203310373782 |
0.372 |
|
| 2010 |
Baker DA, Barth J, Chang R, Obeid LM, Gilkeson GS. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. Journal of Immunology (Baltimore, Md. : 1950). 185: 2570-9. PMID 20644167 DOI: 10.4049/Jimmunol.1000644 |
0.664 |
|
| 2010 |
Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis and Rheumatism. 62: 2467-75. PMID 20506343 DOI: 10.1002/Art.27548 |
0.302 |
|
| 2010 |
Kim-Howard X, Maiti AK, Anaya JM, Bruner GR, Brown E, Merrill JT, Edberg JC, Petri MA, Reveille JD, Ramsey-Goldman R, Alarcon GS, Vyse TJ, Gilkeson G, Kimberly RP, James JA, et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Annals of the Rheumatic Diseases. 69: 1329-32. PMID 19939855 DOI: 10.1136/Ard.2009.120543 |
0.333 |
|
| 2010 |
Sekine H, Kinser T, Martinez E, Paulling E, Qiao F, Ruiz P, Gilkeson G, Tomlinson S. Targeted inhibition of the alternative pathway ameliorates progression of renal disease in murine models of systemic lupus erythematosus Molecular Immunology. 47: 2267-2267. DOI: 10.1016/J.Molimm.2010.05.208 |
0.351 |
|
| 2009 |
Molano I, Mathenia J, Ruiz P, Gilkeson GS, Zhang XK. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clinical and Experimental Immunology. 160: 275-82. PMID 20015093 DOI: 10.1111/J.1365-2249.2009.04080.X |
0.421 |
|
| 2009 |
Webb R, Merrill JT, Kelly JA, Sestak A, Kaufman KM, Langefeld CD, Ziegler J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, Alarcón-Riquelme ME, ... ... Gilkeson GS, et al. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis and Rheumatism. 60: 2402-7. PMID 19644854 DOI: 10.1002/Art.24658 |
0.349 |
|
| 2009 |
Namjou B, Gray-McGuire C, Sestak AL, Gilkeson GS, Jacob CO, Merrill JT, James JA, Wakeland EK, Li QZ, Langefeld CD, Divers J, Ziegler J, Moser KL, Kelly JA, Kaufman KM, et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes and Immunity. 10: 517-24. PMID 19440201 DOI: 10.1038/Gene.2009.33 |
0.328 |
|
| 2009 |
Armstrong DL, Reiff A, Myones BL, Quismorio FP, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ojwang JO, Kaufman KM, Kelly JA, Merrill JT, Harley JB, Bae SC, Vyse TJ, ... Gilkeson GS, et al. Identification of new SLE-associated genes with a two-step Bayesian study design. Genes and Immunity. 10: 446-56. PMID 19440200 DOI: 10.1038/Gene.2009.38 |
0.34 |
|
| 2009 |
Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcón GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, ... ... Gilkeson GS, et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes and Immunity. 10: 457-69. PMID 19387458 DOI: 10.1038/Gene.2009.27 |
0.323 |
|
| 2009 |
Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, Kaufman KM, James JA, Gilkeson GS, Kelly JA, Humphrey MB, Harley JB, Gray-McGuire C, Moser KL, Gaffney PM. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes and Immunity. 10: 470-7. PMID 19387456 DOI: 10.1038/Gene.2009.31 |
0.312 |
|
| 2009 |
Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, et al. Genetic associations of LYN with systemic lupus erythematosus. Genes and Immunity. 10: 397-403. PMID 19369946 DOI: 10.1038/Gene.2009.19 |
0.331 |
|
| 2009 |
Sekine H, Ferreira RC, Pan-Hammarström Q, Hammarström L, Gilkeson GS, Behrens TW. Comment on "Reassessment of the role of mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching". Journal of Immunology (Baltimore, Md. : 1950). 182: 4495-6; author reply. PMID 19342619 DOI: 10.4049/Jimmunol.0990026 |
0.304 |
|
| 2009 |
Guo L, Deshmukh H, Lu R, Vidal GS, Kelly JA, Kaufman KM, Dominguez N, Klein W, Kim-Howard X, Bruner GR, Scofield RH, Moser KL, Gaffney PM, Dozmorov IM, Gilkeson GS, et al. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Genes and Immunity. 10: 531-8. PMID 19339986 DOI: 10.1038/Gene.2009.18 |
0.381 |
|
| 2009 |
Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP, Reiff A, Myones BL, Guthridge JM, Nath SK, ... ... Gilkeson GS, et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis and Rheumatism. 60: 1085-95. PMID 19333953 DOI: 10.1002/Art.24387 |
0.352 |
|
| 2009 |
Webb R, Wren JD, Jeffries M, Kelly JA, Kaufman KM, Tang Y, Frank MB, Merrill J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, ... ... Gilkeson GS, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 60: 1076-84. PMID 19333917 DOI: 10.1002/Art.24360 |
0.38 |
|
| 2009 |
Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, Thomas JA, Reiff A, Myones BL, Ojwang JO, Kaufman KM, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, ... ... Gilkeson GS, et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America. 106: 6256-61. PMID 19329491 DOI: 10.1073/Pnas.0901181106 |
0.407 |
|
| 2009 |
Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F, Tang PH, Kunchithapautham K, Gilkeson GS, Tomlinson S. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Investigative Ophthalmology & Visual Science. 50: 3056-64. PMID 19264882 DOI: 10.1167/Iovs.08-2222 |
0.315 |
|
| 2009 |
Keil DE, Peden-Adams MM, Wallace S, Ruiz P, Gilkeson GS. Assessment of trichloroethylene (TCE) exposure in murine strains genetically-prone and non-prone to develop autoimmune disease. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 44: 443-53. PMID 19241258 DOI: 10.1080/10934520902719738 |
0.437 |
|
| 2009 |
Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM. N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 108: 110-23. PMID 19141786 DOI: 10.1093/Toxsci/Kfp001 |
0.322 |
|
| 2009 |
Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, Hannun YA, Obeid LM. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 143-52. PMID 18815359 DOI: 10.1096/fj.08-118109 |
0.775 |
|
| 2009 |
Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcón GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, ... ... Gilkeson GS, et al. Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing Genes & Immunity. 10: 606-606. DOI: 10.1038/Gene.2009.42 |
0.333 |
|
| 2008 |
Njoku C, Self SE, Ruiz P, Hofbauer AF, Gilkeson GS, Oates JC. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene Journal of Investigative Medicine. 56: 911-919. PMID 18797415 DOI: 10.2310/Jim.0B013E3181889E13 |
0.45 |
|
| 2008 |
Peden-Adams MM, Eudaly JG, Lee AM, Miller J, Keil DE, Gilkeson GS. Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 43: 1402-9. PMID 18780217 DOI: 10.1080/10934520802232063 |
0.371 |
|
| 2008 |
Bradshaw S, Zheng WJ, Tsoi LC, Gilkeson G, Zhang XK. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clinical Immunology (Orlando, Fla.). 129: 19-30. PMID 18692443 DOI: 10.1016/J.Clim.2008.05.010 |
0.795 |
|
| 2008 |
Reilly CM, Thomas M, Gogal R, Olgun S, Santo A, Sodhi R, Samy ET, Peng SL, Gilkeson GS, Mishra N. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice Journal of Autoimmunity. 31: 123-130. PMID 18650065 DOI: 10.1016/J.Jaut.2008.04.020 |
0.37 |
|
| 2008 |
Zhang XK, Moussa O, Larue A, Bradshaw S, Molano I, Spyropoulos DD, Gilkeson GS, Watson DK. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice Journal of Immunology. 181: 1644-1654. PMID 18641300 DOI: 10.4049/Jimmunol.181.3.1644 |
0.792 |
|
| 2008 |
Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkeson GS. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clinical Immunology (Orlando, Fla.). 128: 259-68. PMID 18514033 DOI: 10.1016/J.Clim.2008.03.508 |
0.79 |
|
| 2008 |
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicological Sciences : An Official Journal of the Society of Toxicology. 104: 144-54. PMID 18359764 DOI: 10.1093/Toxsci/Kfn059 |
0.344 |
|
| 2008 |
Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM, Namjou B, Deshmukh H, Bruner G, Espinoza LR, Gilkeson GS, Harley JB, James JA, Nath SK. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. Plos One. 3: e0001757. PMID 18335026 DOI: 10.1371/Journal.Pone.0001757 |
0.329 |
|
| 2008 |
Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, Alarcón-Riquelme ME, James JA, Vyse TJ, Gilkeson GS, Choi CB, Scofield RH, Bae SC, Nath SK, Harley JB. Common variants within MECP2 confer risk of systemic lupus erythematosus. Plos One. 3: e1727. PMID 18320046 DOI: 10.1371/Journal.Pone.0001727 |
0.348 |
|
| 2008 |
Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, Chen W, Zhu C, McEver RP, Kimberly RP, Alarcón-Riquelme ME, Vyse TJ, Li QZ, Wakeland EK, Merrill JT, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nature Genetics. 40: 152-4. PMID 18204448 DOI: 10.1038/Ng.71 |
0.312 |
|
| 2008 |
Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, ... ... Gilkeson GS, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics. 40: 204-10. PMID 18204446 DOI: 10.1038/Ng.81 |
0.316 |
|
| 2008 |
Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. Journal of Immunology (Baltimore, Md. : 1950). 180: 1231-8. PMID 18178863 DOI: 10.4049/jimmunol.180.2.1231 |
0.412 |
|
| 2008 |
Oates JC, Shaftman SR, Self SE, Gilkeson GS. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis and Rheumatism. 58: 263-72. PMID 18163495 DOI: 10.1002/Art.23153 |
0.397 |
|
| 2008 |
Nowling TK, Fulton JD, Chike-Harris K, Gilkeson GS. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. Molecular Immunology. 45: 1-12. PMID 17606295 DOI: 10.1016/J.Molimm.2007.05.018 |
0.376 |
|
| 2008 |
Sekine H, Gilkeson G, Tomlinson S. Targeted inhibition of the alternative pathway by CR2-fH fusion protein ameliorates progression of renal disease in MRL/lpr mice Molecular Immunology. 45: 4153. DOI: 10.1016/J.Molimm.2008.08.173 |
0.362 |
|
| 2008 |
Nath S, Han S, Kim-Howard X, Deshmukh H, Viswanathan P, Bruner G, Kelly J, Gilkeson G, McEver R, Kimberly R, Vyse T, Chen W, Zhu C, Alarcón-Riquelme M, Wakeland E, et al. Sa.54. Positional Identification of Integrin- αMβ2 (ITGAM) as a Susceptibility Gene for Systematic Lupus Erythematosus (SLE) Clinical Immunology. 127: S98. DOI: 10.1016/J.Clim.2008.03.275 |
0.315 |
|
| 2007 |
Oates JC, Farrelly LW, Hofbauer AF, Wang W, Gilkeson GS. Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients Arthritis and Rheumatism. 56: 3738-3747. PMID 17968874 DOI: 10.1002/Art.22955 |
0.356 |
|
| 2007 |
Rohrer B, Guo Y, Kunchithapautham K, Gilkeson GS. Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Investigative Ophthalmology & Visual Science. 48: 5282-9. PMID 17962484 DOI: 10.1167/Iovs.07-0282 |
0.305 |
|
| 2007 |
Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ. Absence of functional alternative complement pathway alleviates lupus cerebritis. European Journal of Immunology. 37: 1691-701. PMID 17523212 DOI: 10.1002/Eji.200636638 |
0.426 |
|
| 2007 |
Lenderink AM, Liegel K, Ljubanović D, Coleman KE, Gilkeson GS, Holers VM, Thurman JM. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy American Journal of Physiology - Renal Physiology. 293. PMID 17522263 DOI: 10.1152/Ajprenal.00403.2006 |
0.392 |
|
| 2007 |
Sekine H, Ferreira RC, Pan-Hammarström Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, ... ... Gilkeson GS, et al. Role for Msh5 in the regulation of Ig class switch recombination. Proceedings of the National Academy of Sciences of the United States of America. 104: 7193-8. PMID 17409188 DOI: 10.1073/Pnas.0700815104 |
0.779 |
|
| 2007 |
Miwa T, Maldonado MA, Zhou L, Yamada K, Gilkeson GS, Eisenberg RA, Song WC. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. The American Journal of Pathology. 170: 1258-66. PMID 17392165 DOI: 10.2353/Ajpath.2007.060601 |
0.47 |
|
| 2007 |
Njoku CJ, Gilkeson GS, Hofbauer A, Ruiz P, Oates JC. THE RESPONSE OF MRL/LPR-INDUCIBLE NITRIC OXIDE SYNTHASE KNOCKOUT MICE TO INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR. Journal of Investigative Medicine. 55: S278. DOI: 10.1097/00042871-200701010-00705 |
0.424 |
|
| 2006 |
Sekine H, Graham KL, Zhao S, Elliott MK, Ruiz P, Utz PJ, Gilkeson GS. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 177: 7423-34. PMID 17082662 DOI: 10.4049/Jimmunol.177.10.7423 |
0.783 |
|
| 2006 |
Nowling TK, Gilkeson GS. Regulation of Fli1 gene expression and lupus. Autoimmunity Reviews. 5: 377-82. PMID 16890890 DOI: 10.1016/J.Autrev.2005.10.005 |
0.353 |
|
| 2006 |
Oates JC, Gilkeson GS. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). 121: 243-50. PMID 16861040 DOI: 10.1016/J.Clim.2006.06.001 |
0.377 |
|
| 2006 |
Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis and Rheumatism. 54: 2198-210. PMID 16804897 DOI: 10.1002/Art.21934 |
0.772 |
|
| 2006 |
Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice European Journal of Immunology. 36: 1296-1308. PMID 16541466 DOI: 10.1002/Eji.200535245 |
0.429 |
|
| 2006 |
Liu J, Karypis G, Hippen KL, Vegoe AL, Ruiz P, Gilkeson GS, Behrens TW. Genomic view of systemic autoimmunity in MRLlpr mice. Genes and Immunity. 7: 156-68. PMID 16508641 DOI: 10.1038/Sj.Gene.6364286 |
0.441 |
|
| 2006 |
Peden-Adams MM, Eudaly JG, Heesemann LM, Smythe J, Miller J, Gilkeson GS, Keil DE. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 41: 249-71. PMID 16484062 DOI: 10.1080/10934520500455289 |
0.309 |
|
| 2006 |
Crosby MB, Zhang J, Nowling TM, Svenson JL, Nicol CJ, Gonzalez FJ, Gilkeson GS. Inflammatory modulation of PPAR gamma expression and activity. Clinical Immunology (Orlando, Fla.). 118: 276-83. PMID 16303334 DOI: 10.1016/J.Clim.2005.09.018 |
0.789 |
|
| 2006 |
Bouali H, Nowling T, Cooper GS, Dooley MA, Nietert PJ, Kamen D, Harley J, Gilkeson G. 245 MYELOPEROXIDASE GENE POLYMORPHISM IN SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS. Journal of Investigative Medicine. 54: S300.1-S300. DOI: 10.2310/6650.2005.X0008.244 |
0.354 |
|
| 2006 |
Oates JC, Njoku CJ, Hofbauer AF, Fleury TW, Gilkeson GS. P148. Serum nitrate and nitrite levels are greater in systemic lupus erythematosus and lupus nephritis in association with disease activity Nitric Oxide. 14: 65. DOI: 10.1016/J.Niox.2006.04.215 |
0.348 |
|
| 2005 |
Bouali H, Gilkeson G. New therapies and preventive strategies to treat and minimize damage in lupus. Current Rheumatology Reports. 7: 457-462. PMID 16303106 DOI: 10.1007/S11926-005-0052-5 |
0.322 |
|
| 2005 |
Crosby MB, Svenson J, Gilkeson GS, Nowling TK. A novel PPAR response element in the murine iNOS promoter. Molecular Immunology. 42: 1303-10. PMID 15950726 DOI: 10.1016/J.Molimm.2004.12.009 |
0.767 |
|
| 2005 |
Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis and Rheumatism. 52: 1148-59. PMID 15818712 DOI: 10.1002/Art.20997 |
0.331 |
|
| 2005 |
Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T, Alarcón-Segovia D, Appel G, Aranow C, Ballou S, Becker MA, Becker N, Belmont MH, Bohan A, Boling EP, ... ... Gilkeson GS, et al. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus Arthritis and Rheumatism. 52: 1129-1137. PMID 15818711 DOI: 10.1002/Art.20980 |
0.333 |
|
| 2005 |
Haraldsson MK, dela Paz NG, Kuan JG, Gilkeson GS, Theofilopoulos AN, Kono DH. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. Journal of Immunology (Baltimore, Md. : 1950). 174: 5065-73. PMID 15814738 DOI: 10.4049/Jimmunol.174.8.5065 |
0.411 |
|
| 2005 |
Thurman JM, Kraus DM, Girardi G, Hourcade D, Kang HJ, Royer PA, Mitchell LM, Giclas PC, Salmon J, Gilkeson G, Holers VM. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice Molecular Immunology. 42: 87-97. PMID 15488947 DOI: 10.1016/J.Molimm.2004.07.043 |
0.394 |
|
| 2005 |
Crosby MB, Svenson JL, Zhang J, Nicol CJ, Gonzalez FJ, Gilkeson GS. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. The Journal of Pharmacology and Experimental Therapeutics. 312: 69-76. PMID 15356214 DOI: 10.1124/Jpet.104.074005 |
0.77 |
|
| 2005 |
Peden-Adams MM, Dudley AC, EuDaly JG, Allen CT, Gilkeson GS, Keil DE. Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacology and Immunotoxicology. 26: 1-15. PMID 15106728 DOI: 10.1081/Iph-120029939 |
0.312 |
|
| 2005 |
Njoku CJ, Gilkeson GS, Patrick KS, Oates JC. 362 EFFECT OF INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS ON ISOPROSTANE PRODUCTION IN MURINE LUPUS NEPHRITIS Journal of Investigative Medicine. 53: S317.4-S317. DOI: 10.2310/6650.2005.00006.361 |
0.339 |
|
| 2005 |
Shu C, Guo L, Bruner G, Gilkeson G, Kamen D, Tang YH, Dozmorov I, Kelly J, Ning J, Williams D, Pongratz C, James J, Guthridge JM, Harley JB. 358 DIFFERENTIAL GENE EXPRESSION IN B CELLS FROM GULLAH LUPUS PATIENTS AND CONTROLS. Journal of Investigative Medicine. 53: S316.6-S317. DOI: 10.2310/6650.2005.00006.357 |
0.348 |
|
| 2004 |
Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus. 13: 784-91. PMID 15540511 DOI: 10.1191/0961203304Lu1085Oa |
0.352 |
|
| 2004 |
Zhang XK, Gallant S, Molano I, Moussa OM, Ruiz P, Spyropoulos DD, Watson DK, Gilkeson G. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice Journal of Immunology. 173: 6481-6489. PMID 15528390 DOI: 10.4049/Jimmunol.173.10.6481 |
0.437 |
|
| 2004 |
Reilly CM, Mishra N, Miller JM, Joshi D, Ruiz P, Richon VM, Marks PA, Gilkeson GS. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. Journal of Immunology (Baltimore, Md. : 1950). 173: 4171-8. PMID 15356168 DOI: 10.4049/Jimmunol.173.6.4171 |
0.451 |
|
| 2004 |
Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. Journal of Immunology (Baltimore, Md. : 1950). 172: 3913-21. PMID 15004199 DOI: 10.4049/Jimmunol.172.6.3913 |
0.396 |
|
| 2004 |
Oates JC, Gilkeson GS. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 52: 62-71. PMID 14989372 DOI: 10.1136/Jim-52-01-29 |
0.411 |
|
| 2004 |
Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice Kidney International. 65: 129-138. PMID 14675043 DOI: 10.1111/J.1523-1755.2004.00371.X |
0.785 |
|
| 2004 |
Qing X, Zavadil J, Crosby M, Gilkeson G, Bottinger E, Putterman C. Gene regulation by a pathogenic anti-DNA antibody in murine lupus mesangial cells Autoimmunity Reviews. 3: 607-609. DOI: 10.1016/J.Autrev.2004.08.023 |
0.765 |
|
| 2003 |
Croker BP, Gilkeson G, Morel L. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus Genes and Immunity. 4: 575-585. PMID 14647198 DOI: 10.1038/Sj.Gene.6364028 |
0.383 |
|
| 2003 |
Guyton K, Zingarelli B, Ashton S, Teti G, Tempel G, Reilly C, Gilkeson G, Halushka P, Cook J. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock. 20: 56-62. PMID 12813370 DOI: 10.1097/01.Shk.0000070903.21762.F8 |
0.364 |
|
| 2003 |
Molano ID, Redmond S, Sekine H, Zhang XK, Reilly C, Hutchison F, Ruiz P, Gilkeson GS. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clinical Immunology (Orlando, Fla.). 107: 186-97. PMID 12804532 DOI: 10.1016/S1521-6616(03)00035-4 |
0.435 |
|
| 2003 |
Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse Journal of Clinical Investigation. 111: 539-552. PMID 12588892 DOI: 10.1172/Jci16153 |
0.402 |
|
| 2003 |
Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice Journal of Immunology. 170: 1517-1523. PMID 12538716 DOI: 10.4049/Jimmunol.170.3.1517 |
0.346 |
|
| 2003 |
Oates JC, Gilkeson GS. Mediators of injury in lupus nephritis. Current Opinion in Rheumatology. 14: 498-503. PMID 12192244 DOI: 10.1097/00002281-200209000-00003 |
0.354 |
|
| 2002 |
Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Hoppin JA, Savitz DA. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis and Rheumatism. 46: 1840-50. PMID 12124868 DOI: 10.1002/Art.10368 |
0.307 |
|
| 2002 |
Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis and Rheumatism. 46: 1830-9. PMID 12124867 DOI: 10.1002/Art.10365 |
0.314 |
|
| 2002 |
Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, Roubey RA, Dooley MA. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 11: 161-7. PMID 11999880 DOI: 10.1191/0961203302Lu161Oa |
0.301 |
|
| 2002 |
Reilly CM, Gilkeson GS. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice Immunologic Research. 25: 143-153. PMID 11999168 DOI: 10.1385/Ir:25:2:143 |
0.46 |
|
| 2002 |
Oates JC, Reilly CM, Crosby MB, Gilkeson GS. Peroxisome proliferator-activated receptor γ agonists: Potential use for treating chronic inflammatory diseases Arthritis and Rheumatism. 46: 598-605. PMID 11920394 DOI: 10.1002/Art.10052 |
0.776 |
|
| 2002 |
Reilly CM, Farrelly LW, Viti D, Redmond ST, Hutchison F, Ruiz P, Manning P, Connor J, Gilkeson GS. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney International. 61: 839-46. PMID 11849435 DOI: 10.1046/j.1523-1755.2002.00230.x |
0.32 |
|
| 2001 |
Pandey JP, Cooper GS, Treadwell EL, Gilkeson GS, St Clair EW, Dooley MA. Immunoglobulin GM and KM allotypes in systemic lupus erythematosus. Experimental and Clinical Immunogenetics. 18: 117-22. PMID 11549840 DOI: 10.1159/000049190 |
0.334 |
|
| 2001 |
Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice Journal of Immunology. 166: 6444-6451. PMID 11342671 DOI: 10.4049/Jimmunol.166.10.6444 |
0.401 |
|
| 2001 |
Reilly CM, Oates JC, Sudian J, Crosby MB, Halushka PV, Gilkeson GS. Prostaglandin J2 inhibition of mesangial cell iNOS expression Clinical Immunology. 98: 337-345. PMID 11237557 DOI: 10.1006/Clim.2000.4985 |
0.783 |
|
| 2001 |
Guyton K, Bond R, Reilly C, Gilkeson G, Halushka P, Cook J. Differential effects of 15-deoxy-Δ12,14-prostaglandin J2 and a peroxisome proliferator-activated receptor γ agonist on macrophage activation Journal of Leukocyte Biology. 69: 631-638. DOI: 10.1189/Jlb.69.4.631 |
0.362 |
|
| 2000 |
Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains Proceedings of the National Academy of Sciences of the United States of America. 97: 6670-6675. PMID 10841565 DOI: 10.1073/Pnas.97.12.6670 |
0.407 |
|
| 2000 |
Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, Gilkeson GS. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-γ agonists Journal of Immunology. 164: 1498-1504. PMID 10640767 DOI: 10.4049/Jimmunol.164.3.1498 |
0.451 |
|
| 2000 |
Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. Journal of Immunology (Baltimore, Md. : 1950). 164: 786-94. PMID 10623824 DOI: 10.4049/Jimmunol.164.2.786 |
0.437 |
|
| 2000 |
Molano ID, Wloch MK, Alexander AA, Watanabe H, Gilkeson GS. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. Clinical Immunology (Orlando, Fla.). 94: 24-32. PMID 10607487 DOI: 10.1006/Clim.1999.4797 |
0.423 |
|
| 2000 |
Sekine H, Colten H, Garnier G, Circolo A, Gilkeson G. Complement factor C3 is not required for full expression of lupus nephritis in MRL/lpr mice Immunopharmacology. 49: 28. DOI: 10.1016/S0162-3109(00)80090-9 |
0.378 |
|
| 1999 |
Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, Wakeland EK. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies Journal of Clinical Investigation. 103: 1685-1695. PMID 10377175 DOI: 10.1172/Jci5827 |
0.423 |
|
| 1998 |
Watanabe H, Sherris D, Gilkeson GS. Soluble CD16 in the treatment of murine lupus nephritis. Clinical Immunology and Immunopathology. 88: 91-5. PMID 9683555 DOI: 10.1006/Clin.1998.4553 |
0.413 |
|
| 1998 |
Watanabe H, Circolo A, Wetsel R, Holers V, Boackle SA, Colten HR, Gilkeson GS. Amelioration of renal disease in lupus mice genetically deficient in complement factor B Molecular Immunology. 35: 336. DOI: 10.1016/S0161-5890(98)90556-9 |
0.394 |
|
| 1998 |
Gilkeson GS, Garnier G, Circolo A, Wetsel R, Holers V, Feagin A, Colten HR. Modulation of renal disease in lupus mice deficient in complement component C3 Molecular Immunology. 35: 336. DOI: 10.1016/S0161-5890(98)90555-7 |
0.382 |
|
| 1997 |
Gilkeson GS, Mudgett JS, Seldin MF, Ruiz P, Alexander AA, Misukonis MA, Pisetsky DS, Weinberg JB. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. The Journal of Experimental Medicine. 186: 365-73. PMID 9236188 DOI: 10.1084/Jem.186.3.365 |
0.431 |
|
| 1997 |
Oates JC, Ruiz P, Alexander A, Pippen AM, Gilkeson GS. Effect of late modulation of nitric oxide production on murine lupus. Clinical Immunology and Immunopathology. 83: 86-92. PMID 9073540 DOI: 10.1006/Clin.1997.4332 |
0.43 |
|
| 1997 |
Pisetsky DS, Gilkeson G, St Clair EW. Systemic lupus erythematosus. Diagnosis and treatment. The Medical Clinics of North America. 81: 113-28. PMID 9012757 DOI: 10.1016/S0025-7125(05)70507-1 |
0.36 |
|
| 1996 |
Gilkeson GS, Ruiz P, Pippen AM, Alexander AL, Lefkowith JB, Pisetsky DS. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. The Journal of Experimental Medicine. 183: 1389-97. PMID 8666897 DOI: 10.1084/jem.183.4.1389 |
0.302 |
|
| 1994 |
Palmer SM, Gilkeson GS, Pisetsky DS. Effect of sex on the induction of anti-DNA antibodies in normal mice immunized with bacterial DNA. Lupus. 2: 251-5. PMID 8268973 DOI: 10.1177/096120339300200408 |
0.339 |
|
| 1991 |
Gilkeson GS, Ruiz P, Pritchard AJ, Pisetsky DS. Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids Journal of Autoimmunity. 4: 595-606. PMID 1777011 DOI: 10.1016/0896-8411(91)90179-G |
0.317 |
|
| 1989 |
Gilkeson GS, Ruiz P, Grudier JP, Kurlander RJ, Pisetsky DS. Genetic control of inflammatory arthritis in congenic lpr mice. Clinical Immunology and Immunopathology. 53: 460-74. PMID 2805451 DOI: 10.1016/0090-1229(89)90008-1 |
0.396 |
|
| Show low-probability matches. |